Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2006
03/30/2006WO2005118643A3 Antibodies to angiogenesis inhibiting domains of cd148
03/30/2006WO2005117994A9 Bmp pathway methods and compositions
03/30/2006WO2005113779A3 Plant myo-inositol kinase polynucleotides and methods of use
03/30/2006WO2005084115A3 Ttg3 deficient plants, nucleic acids, polypetides and methods of use thereof
03/30/2006WO2005072112A3 Methods for producing and identifying multispecific antibodies
03/30/2006WO2005068612A3 Human hepatic progenitor cells and methods of use thereof
03/30/2006WO2004096978A3 Production of high mannose proteins in plant culture
03/30/2006WO2004076624A3 Compositions and methods for neural cell production and stabilization
03/30/2006WO2004053071A3 Method for discovering neurogenic agents
03/30/2006WO2004048594A3 Preparation and use of single-stranded transcription substrates for synthesis of transcription products corresponding to target sequences
03/30/2006WO2003062369A3 Expansion of renewable stem cell populations
03/30/2006WO2003014294A3 Tacis and br3 polypeptides and uses thereof
03/30/2006US20060070141 Method of repressing flowering in a plant
03/30/2006US20060070140 Promoter molecules for use in plants
03/30/2006US20060070139 Corn event DAS-59122-7 and methods for detection thereof
03/30/2006US20060070138 Seed of cotton cultivar produced by crossing the cultivar 03X179R with itself or another cotton cultivar; insect resistance, herbicide resistance, sterility, enhanced fiber quality
03/30/2006US20060070136 GLYT1 transgenic mouse
03/30/2006US20060069246 Tumor necrosis factor receptor related proteins Tango-63d and Tango-63e
03/30/2006US20060069242 Neurotrophic factor receptor
03/30/2006US20060069053 Methods and compositions for enhancing cartilage repair
03/30/2006US20060069050 Methods and compositions for mediating gene silencing
03/30/2006US20060069025 Survivin, a protein that inhibits cellular apoptosis, and its modulation
03/30/2006US20060068497 Methods for isolating novel antimicrobial agents from hypermutable mammalian cells
03/30/2006US20060068496 Differentiation of stem cells
03/30/2006US20060068495 Process of cell electrofusion
03/30/2006US20060068494 WNT4 in supporting lymphopoiesis
03/30/2006US20060068471 Soluble zcytor 11 cytokine receptors
03/30/2006US20060068470 Antifreeze proteins from basidiomy cetes
03/30/2006US20060068466 Used in assays for the identification of new agents for anesthesia and analgesia
03/30/2006US20060068463 Natural killer cell activating factor ii
03/30/2006US20060068453 Survivin, a protein that inhibits cellular apoptosis, and its modulation
03/30/2006US20060068439 Ucp4
03/30/2006US20060068423 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/30/2006US20060068413 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/30/2006US20060068404 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/30/2006US20060068370 Includes a proximal regulatory sequence and a distal enhancer of 5' flanking region of human alpha -fetoprotein (AFP) gene
03/30/2006US20060068060 Carboxypeptidase of cocoa
03/30/2006US20060067940 Monoclonal antibody or an antigen binding fragment that specifically binds amino acids of a West Nile virus E protein
03/30/2006US20060067936 IL-23p40 specific immunoglobulin derived proteins, compositions, epitopes, methods and uses
03/30/2006US20060067918 Neural stem cell culture for prevention and treatment of brain and nervous sytem disorders
03/30/2006US20060067916 Sperm cell process system
03/30/2006US20060067914 Immortalized natural killer cell line
03/30/2006US20060067912 Methods for the induction of professional and cytokine-producing regulatory T cells
03/30/2006DE19824384B4 Herstellung von Primmorphen aus dissoziierten Zellen von Schwämmen und Korallen, Verfahren zur Kultivierung von Zellen von Schwämmen und Korallen zur Produktion und Detektion von bioaktiven Substanzen, zur Detektion von Umweltgiften und zur Kultivierung dieser Tiere in Aquarien und im Freiland Preparation of primmorphs from dissociated cells from sponges and corals, methods for culturing cells for the production of sponges, corals and detection of bioactive substances, for the detection of environmental toxins and for the cultivation of these animals in aquariums and in the open
03/30/2006DE10105420B4 In vitro Zellinteraktionskultursystem für Medikamententestung und -entwicklung In vitro cell culture system for drug interaction testing and development
03/30/2006CA2798495A1 Plant cells and plants with increased tolerance to environmental stress
03/30/2006CA2581341A1 Genetic selection of small molecule modulators of protein-protein interactions
03/30/2006CA2581237A1 Method of enhancing proliferation and/or survival of mesenchymal precursor cells (mpc)
03/30/2006CA2581091A1 Mycer immortalized hepatocyte
03/30/2006CA2580975A1 Multipotential expanded mesenchymal precursor cell progeny (memp) and uses thereof
03/30/2006CA2580754A1 Compositions and methods for stem cell expansion and differentiation
03/30/2006CA2580736A1 Arabidopsis genes encoding proteins involved in sugar and lipid metabolism and methods of use
03/30/2006CA2577632A1 Intestinal epithelial glucose sensor
03/30/2006CA2571272A1 Anti-lympho- plus anti-monocytes globulin preparation for inhibiting immune responses
03/30/2006CA2521421A1 C-mycer.tam. induced human neural stem cell lines
03/29/2006EP1640898A1 Medical care self-cell delivery support system, medical care self-cell delivery support financial system, and their methods
03/29/2006EP1640716A1 Blood cell separation membrane and blood retention tool including the same
03/29/2006EP1640450A1 Process for producing retinal neurocyte from neural stem cell derived from iris tissue and retinal neurocyte produced by the process
03/29/2006EP1640449A1 Cell differentiation inhibiting agent, cell culture method using the same, culture medium and cultured cell line
03/29/2006EP1640448A2 Primate embryonic stem cells
03/29/2006EP1640381A2 Neurotrophic growth factor
03/29/2006EP1640024A2 Cell-coated support
03/29/2006EP1639369A2 Plasma polymerisation methods for the deposition of chemical gradients and surfaces displaying a gradient of immobilised biomolecules
03/29/2006EP1639112A2 Novel beta-actin and rps21 promoters and uses thereof
03/29/2006EP1639111A2 Protein expression system
03/29/2006EP1639109A2 Dna vectors
03/29/2006EP1639099A1 Method of isolating cells from umbilical cord
03/29/2006EP1639097A2 Methods and compositions for modulating stem cell growth and differentiation
03/29/2006EP1639096A2 Methods of producing neurons
03/29/2006EP1639095A2 Method to increase protein production in culture
03/29/2006EP1639092A2 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
03/29/2006EP1639090A2 Compositions and methods for treating and diagnosing cancer
03/29/2006EP1639089A2 Transcription factor
03/29/2006EP1639013A2 Pan-kir2dl nk-receptor antibodies and their use in diagnostik and therapy
03/29/2006EP1639009A1 Fab library for the preparation of anti vegf and anti rabies virus fabs
03/29/2006EP1639003A1 Use of cardiotrophin to modulate stem cell proliferation
03/29/2006EP1639001A1 Method for transplanting lymphohematopoietic cells into mammal
03/29/2006EP1638606A2 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
03/29/2006EP1638587A2 Contraceptive methods and compositions related to proteasomal interference
03/29/2006EP1638507A2 Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
03/29/2006EP1506294B1 Hydantoin racemase
03/29/2006EP1434855A4 Adipose-derived stem cells and lattices
03/29/2006EP1358354B1 Method for identifying compounds modulating reverse cholesterol transport
03/29/2006EP1346039B1 Human cervical cancer 2 protooncogene and protein encoded therein
03/29/2006EP1305402B1 Lipo-viro-particle complexes, preparation method and uses
03/29/2006EP1222266B1 Pca3 messenger rna in benign and malignant prostate tissues
03/29/2006EP1171006B1 Functionalized poly(propylene fumarate) and poly(propylene fumarate-co-ethylene glycol)
03/29/2006EP1137943B1 Cancer detection method and reagents
03/29/2006EP1088090B1 Inducible promoters
03/29/2006EP1050542B1 Novel potassium channel protein
03/29/2006EP1007627B1 Extracellular serine protease
03/29/2006EP1005363B1 Recombinant dimeric envelope vaccine against flaviviral infection
03/29/2006EP0990031B1 Tumor necrosis factor receptor 5
03/29/2006EP0961829B1 Fusion proteins for intracellular and intercellular transport and their uses
03/29/2006EP0944722B1 Pituitary-tumor-transforming-genes, and related products
03/29/2006EP0918797B1 Humanized immunoglobulin reactive with alpha4beta7 integrin
03/29/2006EP0914427B1 Plasmid-based vaccine for treating atherosclerosis
03/29/2006EP0837944B1 Mutated 5-enol pyruvylshikimate-3-phosphate synthase, gene coding for said protein and transformed plants containing said gene
03/29/2006EP0832254B1 An autoregulatory tetracycline-regulated system for inducible gene expression in eucaryotes
03/29/2006EP0751709B2 Use of bcl-2 for the manufacture of medicaments for the therapeutic treatment and prevention of diseases